Medicine and Dentistry
Acute Leukemia
61%
Assay
10%
Association
13%
Atherosclerosis
7%
Biological Marker
66%
Cell Adhesion Molecule
15%
Cell Function
33%
Cell Migration
9%
Cell Survival
33%
Cells
7%
Circulating microRNA
33%
Clinical Study
33%
Colon Cancer
7%
Combination Therapy
33%
Complication
7%
Dasatinib
19%
Diffuse Large B-Cell Lymphoma
33%
Disseminated Intravascular Coagulation
33%
Endothelial Cell
66%
Endothelial Leukocyte Adhesion Molecule 1
7%
Evolution
12%
Hypoxia
33%
In Vitro
37%
Inpatient
57%
Intercellular Adhesion Molecule 1
14%
Interleukin 6
11%
Interleukin 8
11%
microRNA
20%
Neoplasm
79%
Nilotinib
11%
Patient
73%
Patient with Crohn's Disease
33%
Phenotype
37%
Plasma
20%
Ponatinib
14%
Procoagulant
33%
Prognosis
15%
Programmed Cell Death
10%
Prostaglandin Synthase
7%
Spontaneous Remission
12%
Therapeutic Procedure
29%
Thrombin
7%
Thromboplastin
7%
Thrombosis
33%
Tyrosine-Kinase Inhibitor
33%
Vascular Cell Adhesion Molecule 1
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
33%
Apoptosis
5%
Artery Occlusion
6%
Atherogenesis
5%
Atherosclerosis
7%
Azathioprine
33%
Blood Vessel Occlusion
6%
Bosutinib
15%
Cardiovascular Risk
6%
Cell Adhesion Molecule
12%
Chronic Myeloid Leukemia
71%
Comorbidity
6%
Crohn Disease
33%
Dasatinib
44%
Disseminated Intravascular Clotting
33%
E-Selectin
7%
Gelatin
8%
Gelatinase A
15%
Gelatinase B
15%
Imatinib
22%
Intercellular Adhesion Molecule 1
7%
Lactate Dehydrogenase
5%
Long Term Survival
33%
Matrix Metalloproteinase
6%
Metabolic Syndrome X
6%
Myeloid Leukemia
6%
Necrosis
5%
Nilotinib
49%
Overall Survival
33%
Ponatinib
45%
Protein Tyrosine Kinase Inhibitor
100%
Random Effects Model
5%
Randomized Clinical Trial
6%
Randomized Controlled Trial
5%
Rupture
33%
Survival
33%
Vascular Cell Adhesion Molecule 1
7%
Biochemistry, Genetics and Molecular Biology
Adhesion
13%
Aggressiveness
6%
Anticancer
6%
Association
33%
Cancer Cell
33%
Cell Proliferation
6%
Chemosensitivity
6%
Cisplatin
33%
Cochrane Library
5%
Colon
13%
Dasatinib
11%
Data Base
5%
Data Extraction
5%
Data Synthesis
5%
Disseminated Intravascular Coagulation
33%
DNA Repair
6%
Flow
6%
Imatinib
11%
Inflammatory Cytokine
6%
Inhibitor of Apoptosis
6%
Intercellular Adhesion Molecule
13%
Interleukin 6
20%
Interleukin 8
20%
Leukocytes
6%
Macrophage Inflammatory Protein
6%
Messenger RNA
6%
Messenger RNA
6%
Molecule
6%
Monocyte
6%
Mouse
6%
Murine
6%
Myeloid
33%
Nilotinib
16%
Overall Survival
40%
Oxygen Tissue Level
6%
Phenotype
33%
Ponatinib
16%
Prostaglandin-Endoperoxide Synthase 2
13%
Protein
20%
Randomized Clinical Trial
5%
RNA Sequence
6%
Scopus
5%
Stromal Cell
6%
Taxonomy
33%
Time
5%
Transmembrane Protein
6%
Tumor Necrosis Factors
6%
Tumor Progression
13%
Tyrosine Kinase Inhibitor
33%
Ultracentrifugation
11%